Clinical relevance of genotyping ER positive breast cancer
Genomic alteration of the PI3K/AKT pathway
Date
19 Dec 2015Session
Clinical relevance of genotyping ER positive breast cancerPresenters
Fabrice AndréAuthors
F. AndréAuthor affiliations
- Breast Cancer Unit, Institut Gustave Roussy, 94800 - Villejuif/FR
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
ESR1 mutations
Presenter: Takayuki Iwamoto
Session: Clinical relevance of genotyping ER positive breast cancer
Resources:
Slides
Webcast
Emerging treatment options in the genomic era
Presenter: Janice Wing-Hang Tsang
Session: Clinical relevance of genotyping ER positive breast cancer
Resources:
Slides
Webcast
Should I order sequencing for my patients with ER positive metastatic breast cancer?
Presenter: Soonmyung Paik
Session: Clinical relevance of genotyping ER positive breast cancer
Resources:
Slides
Webcast